INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,788,111 | +25.8% | 56,550 | +62.3% | 0.00% | 0.0% |
| Q2 2023 | $1,421,061 | -48.8% | 34,847 | -53.2% | 0.00% | -50.0% |
| Q1 2023 | $2,772,813 | -29.1% | 74,398 | -33.6% | 0.00% | -33.3% |
| Q4 2022 | $3,910,332 | -35.9% | 112,076 | +2.8% | 0.01% | -33.3% |
| Q3 2022 | $6,103,165 | +67.7% | 109,063 | +55.1% | 0.01% | 0.0% |
| Q2 2022 | $3,640,000 | -72.8% | 70,315 | -61.9% | 0.01% | -67.9% |
| Q1 2022 | $13,398,000 | +320.9% | 184,373 | +584.9% | 0.03% | +366.7% |
| Q4 2021 | $3,183,000 | -11.3% | 26,921 | +0.6% | 0.01% | -14.3% |
| Q3 2021 | $3,590,000 | -11.7% | 26,761 | +6.6% | 0.01% | -12.5% |
| Q2 2021 | $4,064,000 | +110.6% | 25,099 | +4.4% | 0.01% | +100.0% |
| Q1 2021 | $1,930,000 | +60.8% | 24,049 | +9.1% | 0.00% | +100.0% |
| Q4 2020 | $1,200,000 | +264.7% | 22,051 | +33.1% | 0.00% | +100.0% |
| Q3 2020 | $329,000 | +2.5% | 16,569 | +8.5% | 0.00% | 0.0% |
| Q2 2020 | $321,000 | +34.9% | 15,270 | -21.6% | 0.00% | 0.0% |
| Q1 2020 | $238,000 | -12.5% | 19,466 | +4.8% | 0.00% | 0.0% |
| Q4 2019 | $272,000 | +38.8% | 18,567 | +26.4% | 0.00% | – |
| Q3 2019 | $196,000 | -18.7% | 14,693 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $241,000 | -1.6% | 14,693 | +2.6% | 0.00% | 0.0% |
| Q1 2019 | $245,000 | +25.0% | 14,327 | 0.0% | 0.00% | – |
| Q4 2018 | $196,000 | -46.6% | 14,327 | +11.9% | 0.00% | -100.0% |
| Q3 2018 | $367,000 | +4.9% | 12,809 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $350,000 | – | 12,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |